May 31 (Reuters) - Mana Capital Acquisition Corp :
* MANA CAPITAL ACQUISITION CORP. AND CARDIO DIAGNOSTICS, INC. ANNOUNCE DEFINITIVE BUSINESS COMBINATION AGREEMENT TO CREATE PUBLICLY LISTED COMPANY SET TO TRANSFORM CARDIOVASCULAR DISEASE THROUGH EPIGENETICS
* MANA CAPITAL - CARDIO DIAGNOSTICS' CASH ON BALANCE SHEET PRIOR TO CLOSING IS EXPECTED TO FUND COMBINED COMPANY'S OPERATIONS THROUGH END OF 2023
* MANA CAPITAL ACQUISITION CORP - COMBINED COMPANY'S CHAIRMAN WILL BE WARREN HOSSEINION
* MANA CAPITAL ACQUISITION CORP - UPON CLOSING OF TRANSACTION, MANA WILL BE RENAMED CARDIO DIAGNOSTICS HOLDINGS, INC
* MANA CAPITAL ACQUISITION CORP - EXPECTS TO REMAIN LISTED ON NASDAQ GLOBAL MARKET UNDER A NEW TICKER SYMBOL "CDIO".
* MANA - COMBINED COMPANY IS EXPECTED TO HAVE AN APPROXIMATE POST-TRANSACTION EQUITY MARKET CAPITALIZATION OF $175 MILLION ASSUMING NO REDEMPTIONS
* MANA-CURRENT CARDIO DIAGNOSTICS MANAGEMENT, EMPLOYEES,EXISTING SHAREHOLDERS WILL ROLL 100% OF EXISTING EQUITY HOLDINGS INTO EQUITY OF COMBINED COMPANY
Source text for Eikon: Further company coverage: